Enteroviruses (EVs), such as EV-D68, EV-A71, and CVB3, cause significant human disease; yet, no antivirals are currently approved. The highly conserved 2C protein, an essential AAA+ ATPase and helicase, is a prime antiviral target; however, it lacks suitable assays for inhibitor screening. Here, we report a fluorescence polarization (FP) assay using a rationally designed probe, Jun14157 , which binds a conserved allosteric site in 2C with high affinity. This assay enables the quantitative assessment of binding to diverse 2C inhibitors with high signal-to-background ratios, DMSO tolerance, and a strong correlation between FP K i and cellular EC 50 . Using this platform, we validated hits from virtual screening a... More
Enteroviruses (EVs), such as EV-D68, EV-A71, and CVB3, cause significant human disease; yet, no antivirals are currently approved. The highly conserved 2C protein, an essential AAA+ ATPase and helicase, is a prime antiviral target; however, it lacks suitable assays for inhibitor screening. Here, we report a fluorescence polarization (FP) assay using a rationally designed probe, Jun14157 , which binds a conserved allosteric site in 2C with high affinity. This assay enables the quantitative assessment of binding to diverse 2C inhibitors with high signal-to-background ratios, DMSO tolerance, and a strong correlation between FP K i and cellular EC 50 . Using this platform, we validated hits from virtual screening and identified two novel inhibitors, Jun15716 and Jun15799 . This FP assay offers a robust and scalable tool for the mechanistic characterization and high-throughput screening of 2C-targeting antivirals.
